Cargando…
The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
The specificity of the tube LAI in breast cancer was examined in a study with coded samples of PBL. In addition, 64 patients with breast cancer had their LAI reactivity monitored and correlated with their clinical status for up to 3 years after mastectomy. When patients were assayed by tube LAI, 83,...
Autores principales: | Lopez, M., O'Connor, R., MacFarlane, J. K., Thomson, D. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009831/ https://www.ncbi.nlm.nih.gov/pubmed/369585 |
Ejemplares similares
-
A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
por: O'Connor, R., et al.
Publicado: (1978) -
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
por: Marti, J. H., et al.
Publicado: (1976) -
Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
por: Vose, B. M., et al.
Publicado: (1979) -
Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
por: Dusheiko, G. M., et al.
Publicado: (1979) -
The leucocyte adherence inhibtion test in cancer of the large bowel.
por: Armitstead, P. R., et al.
Publicado: (1975)